The “-Omics” of the New Bronchopulmonary Dysplasia
• Traditional biomarkers are not very useful in bronchopulmonary dysplasia (BPD) as the pathogenesis of BPD is multifactorial and the clinical phenotype is variable. • Novel systems biology–based “-omic” approaches…